Clinical trials
Diabetes Mellitus, Type 1 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 6 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 17 |
| Eli Lilly and Company | 3 |
| Hirabai Cowasji Jehangir Medical Research Institute | 3 |
| MacroGenics | 2 |
| BIOTRONIK Asia Pacific Pte Ltd | 1 |
| Biocon Limited | 1 |
| Chromaderm, Inc. | 1 |
| Command Hospital, India | 1 |
| Jothydev's Diabetes and Research Centre | 1 |
| Kem Hospital, Pune, India | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 36 |
| Diabetes Mellitus | 15 |
| Diabetes Mellitus, Type 2 | 13 |
| Diabetic Neuropathies | 2 |
| Angina Pectoris | 1 |
| Asthma | 1 |
| Coronary Artery Disease | 1 |
| Hypoglycemia | 1 |
| Ischemia | 1 |
| Myocardial Ischemia | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.